M&R Capital Management Inc Gilead Sciences, Inc. Transaction History

M&R Capital Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$64.88 - $73.64 $6,488 - $7,364	-100 Closed	0 $0
Q1 2021 Apr 01, 2021	SELL	$60.0 - $68.46 $12,000 - $13,691	-200 Reduced 66.67%	100 $6,000
Q4 2020 Jan 05, 2021	SELL	$56.65 - $64.55 $14,162 - $16,137	-250 Reduced 45.45%	300 $17,000
Q4 2019 Jan 07, 2020	BUY	$61.62 - $67.78 $15,405 - $16,945	250 Added 83.33%	550 $35,000
Q3 2019 Oct 02, 2019	BUY	$62.51 - $69.0 $6,251 - $6,900	100 Added 50.0%	300 $19,000
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $71,150 - $83,520	-1,000 Reduced 83.33%	200 $14,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $72,110 - $85,470	1,000 Added 500.0%	1,200 $97,000
Q2 2017 Aug 15, 2017	BUY	N/A	200	200 $14,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on M&R Capital Management Inc with notifications on news.